Murine Cytomegalovirus Protein pM49 Interacts with pM95 and Is Critical for Viral Late Gene Expression

Abstract

Late gene expression of betaherpesviruses and gammaherpesviruses is tightly controlled by virus-encoded transactivation factors (vTFs). We recently proved that the 6 vTFs of murine cytomegalovirus (MCMV) form a complex to regulate late gene transcription. pM49, one of the vTFs that has not been studied before, was identified to be a component of the complex that interacts with pM95. In this study, we began to investigate the potential role of pM49 in viral late gene expression. A recombinant MCMV expressing C-terminal FLAG-tagged pM49 was constructed to study the expression kinetics and localization of pM49. pM49 was expressed at the late time of virus infection. Inhibition of viral DNA synthesis by phosphonate sodium phosphonic acid (PAA) abolished pM49 expression, indicating that it is a late protein. pM49 colocalized with pM44 at the viral replication compartment, similarly to other viral vTFs that have been reported. Mutant virus lacking full-length pM49 expression failed to express viral late genes, leading to nonproductive infection. The expression of immediate early and early genes was not affected, and viral DNA synthesis was only minimally affected during pM49-deficient virus infection. All of these data support the role of pM49 in viral late gene expression. After a series of mutagenesis analyses, two key residues, K325 and C326, were identified as required for pM49-pM95 interaction. Cells expressing pM49 with either single mutation of these two residues failed to rescue the late gene expression and support the replication of pM49-deficient virus. Our results indicated that pM49-pM95 interaction is essential for viral late gene expression. IMPORTANCE Cytomegalovirus (CMV) infections result in morbidity and mortality in immunocompromised individuals, and the virus is also a major cause of birth defects in newborns. Currently, because of the unavailability of vaccines against this virus and restricted antiviral therapies with low toxicity, as well as the emergency of resistant strain of this virus, the understanding of viral late gene regulation may provide clues to study new antiviral drugs or vaccines. In this study, we report that MCMV protein pM49 is critical for viral late gene transcription, based on its interaction with pM95. This finding reveals the important role of pM49-pM95 interaction in the regulation of viral late gene expression and that it could be a future potential target for therapeutic intervention in CMV diseases.

Cytomegalovirus late transcription factor target sequence diversity orchestrates viral early to late transcription

“…For both beta-and gammaherpesviruses, a change in mature mRNA level resulting from the absence of an LTF has been the standard measurement used to identify an LTF-activated viral gene [4,[11][12][13][14][15][16][17][18][19][20]. Possible hidden effects on processing or stability of transcripts complicates the interpretation of results produced by this type of measurement.…”

Resveratrol Inhibits Pseudorabies Virus Replication by Targeting IE180 Protein

“…Immediately after infection, a set of viral gene products requiring no prior viral protein synthesis is named immediately early gene products, such as IE180, ICP4, and ICP27. These proteins are largely responsible for activating early gene transcription and remolding the microenvironment to support viral replication ( Han et al, 2020 ). IE180 has been identified as a potential transcriptional activator.…”

Decoding murine cytomegalovirus

“…In contrast to viral ie gene expression (α genes), the expression of E genes (β genes) requires de novo expression of the major viral transcription factor IE3 and thus viral protein synthesis [5]. Viral L gene expression depends on viral DNA replication as well as expression of the viral late gene transcription factor (LTF) complex that binds to a TATA-like (TATT) motif in the proximal promoters of viral late genes [6][7][8][9][10]. L genes were further sub-divided into leaky late (γ1) and true late (γ2) genes based on their differential sensitivity to DNA synthesis inhibitors [11].…”